Literature DB >> 34976291

Sodium Thiosulfate as a Treatment for Calciphylaxis.

Natsinee Tangkijngamvong1,2,3,4, Paweena Susantitaphong1,2,3,4, Numphung Numkarunarunrote1,2,3,4, Onanong Jearnsujitwimol1,2,3,4, Pravit Asawanonda1,2,3,4, Pawinee Rerknimitr1,2,3,4.   

Abstract

The use of sodium thiosulfate has emerged as a promising treatment for calciphylaxis, albeit inconclusively in terms of efficacy and variable outcomes. Research in this field has been limited by a paucity of samples due to the rarity of the disease. We herein discuss eight calciphylaxis patients' responses to STS, the potential predictive factors affecting outcomes and compare our results with previously published literature. We are able to show that lesion severity, concomitant drugs, and dialysis duration may be predictive factors of outcomes. Further, improvement of the wound site may be a clinically relevant prognostic determinant.
Copyright © 2021. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Calciphylaxis; outcome; sodium thiosulfate

Year:  2021        PMID: 34976291      PMCID: PMC8711617     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  12 in total

1.  Sodium thiosulfate as a treatment for calciphylaxis: A case series.

Authors:  Pieter Bourgeois; Petra De Haes
Journal:  J Dermatolog Treat       Date:  2016-04-07       Impact factor: 3.359

2.  Efficacy of sodium thiosulfate for the treatment for calciphylaxis.

Authors:  L Noureddine; M Landis; N Patel; S M Moe
Journal:  Clin Nephrol       Date:  2011-06       Impact factor: 0.975

3.  Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients.

Authors:  Emanuel Zitt; Matthias König; Andreas Vychytil; Martin Auinger; Manfred Wallner; Gernot Lingenhel; Gernot Schilcher; Michael Rudnicki; Hermann Salmhofer; Karl Lhotta
Journal:  Nephrol Dial Transplant       Date:  2013-01-04       Impact factor: 5.992

4.  Multi-intervention management of calciphylaxis: a report of 7 cases.

Authors:  Corisande Baldwin; Myriam Farah; Marianna Leung; Paul Taylor; Ronald Werb; Mercedeh Kiaii; Adeera Levin
Journal:  Am J Kidney Dis       Date:  2011-08-26       Impact factor: 8.860

5.  Determinants of survival in patients with calciphylaxis: a multivariate analysis.

Authors:  Geeta Lal; Andrew G Nowell; Junlin Liao; Sonia L Sugg; Ronald J Weigel; James R Howe
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

6.  Sodium thiosulfate therapy for calcific uremic arteriolopathy.

Authors:  Sagar U Nigwekar; Steven M Brunelli; Debra Meade; Weiling Wang; Jeffrey Hymes; Eduardo Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 8.237

Review 7.  Sodium thiosulfate in the treatment of calcific uremic arteriolopathy.

Authors:  Georg Schlieper; Vincent Brandenburg; Markus Ketteler; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2009-09       Impact factor: 28.314

8.  Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data.

Authors:  Hermann Salmhofer; Michael Franzen; Wolfgang Hitzl; Josef Koller; Bernhard Kreymann; Falko Fend; Cornelia Hauser-Kronberger; Uwe Heemann; Frieder Berr; Christoph Schmaderer
Journal:  Kidney Blood Press Res       Date:  2013-09-22       Impact factor: 2.687

9.  Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysis.

Authors:  Suwasin Udomkarnjananun; Kitravee Kongnatthasate; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  Kidney Int Rep       Date:  2018-10-09

10.  Multimodal treatment of calcific uraemic arteriolopathy (calciphylaxis): a case series.

Authors:  Domenico Russo; Alfredo Capuano; Mario Cozzolino; Paola Napolitano; Francesca Mosella; Luigi Russo; Caterina Saviano; Carmine Zoccali
Journal:  Clin Kidney J       Date:  2015-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.